DPP4 Inhibitors for Target Therapy Resistance in Renal Cell Carcinoma
September 20, 2023
PRESS RELEASE: On September 15, 2023, a new editorial was published in Oncotarget, entitled, “Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma.” continue reading »